AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (February 19, 2002). doi:10.1152/ajpendo.00486.2001
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/6/E1385    most recent
00486.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamada, T.
Right arrow Articles by Oka, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamada, T.
Right arrow Articles by Oka, Y.

Articles in PresS, published online ahead of print February 19, 2002
Am J Physiol Endocrinol Metab, 10.1152/ajpendo.00486.2001
Submitted on October 31, 2001
Accepted on February 1, 2002

Role of PDK1 in Insulin Signaling Pathway for Glucose Metabolism in 3T3-L1 Adipocytes

Tetsuya Yamada1, Hideki Katagiri2, Tomoichiro Asano3, Masatoshi Tsuru4, Kouichi Inukai5, Hiraku Ono6, Tatsuhiko Kodama7, Masatoshi Kikuchi6, and Yoshitomo Oka1*

1 Division of Molecular Metabolism and Diabetes, Department of Internal Medicine, Tohoku University Graduate School of Medicine, Seiryo-machi, Sendai, Japan; Third Department of Internal Medicine, Yamaguchi University School of Medicine, Ube, Yamaguchi, Japan
2 Division of Molecular Metabolism and Diabetes, Department of Internal Medicine, Tohoku University Graduate School of Medicine, Seiryo-machi, Sendai, Japan
3 Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan
4 Third Department of Internal Medicine, Yamaguchi University School of Medicine, Ube, Yamaguchi, Japan
5 The Fourth Department of Medicine, Saitama Medical School, Moroyama, Iruma-gun, Saitama, Japan
6 The Institute for Adult Disease, Asahi Life Foundation, Shinjuku-ku, Tokyo, Japan
7 Department of Molecular Biology and Medicine, Research Center for Advanced Science and Technology, University of Tokyo, Meguro-ku, Tokyo, Japan

* To whom correspondence should be addressed. E-mail: oka{at}int3.med.tohoku.ac.jp.

To investigate the role of 3-phosphoinositide-dependent protein kinase 1 (PDK1) in the insulin signaling pathway for glucose metabolism, wild-type (wt) PDK1, the kinase-dead (kd), or the plecstrin homology domain deletion ({Delta}PH) mutant of PDK1, was expressed using an adenovirus gene transduction system in 3T3-L1 adipocytes. wt-PDK1 and kd-PDK1 were found in both membrane and cytosol fractions, while {Delta}PH-PDK1, which exhibited PDK1 activity similar to that of wt-PDK1, was detected exclusively in the cytosol fraction. Insulin dose-dependently activated PKB, but did not change atypical PKC (aPKC) activity in control cells. aPKC activity was not affected by expression of wt, kd or {Delta}PH-PDK1 in either the presence or the absence of insulin. Overexpression of wt-PDK1 enhanced insulin-induced activation of PKB as well as insulin-induced phosphorylation of glycogen synthase kinase (GSK) 3{alpha}/ß, a direct downstream target of PKB, although insulin-induced glycogen synthesis was not significantly enhanced by wt-PDK1 expression. Neither {Delta}PH-PDK1 nor kd-PDK1 expression affected PKB activity, GSK3 phosphorylation or glycogen synthesis. Thus, membrane localization of PDK1 via its PH domain is essential for insulin signaling through the PDK1-PKB-GSK3{alpha}/ßpathway. Glucose transport activity was unaffected by expression of wt-PDK1, kd-PDK1, or {Delta}PH-PDK1 in either the presence or the absence of insulin. These findings suggest the presence of a signaling pathway for insulin-stimulated glucose transport, in which PDK1 to PKB or aPKC is not involved.




This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
J. Chunqiu Hou and J. E. Pessin
Lipid Raft Targeting of the TC10 Amino Terminal Domain Is Responsible for Disruption of Adipocyte Cortical Actin
Mol. Biol. Cell, September 1, 2003; 14(9): 3578 - 3591.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Y.-B. Kim, K. Kotani, T. P. Ciaraldi, R. R. Henry, and B. B. Kahn
Insulin-Stimulated Protein Kinase C {lambda}/{zeta} Activity Is Reduced in Skeletal Muscle of Humans With Obesity and Type 2 Diabetes: Reversal With Weight Reduction
Diabetes, August 1, 2003; 52(8): 1935 - 1942.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2002 by the American Physiological Society.